FDA's New Top Medical Device Evaluator Highlights Advancements in Product Evaluation
Wednesday, 25 September 2024, 10:03
FDA's New Leadership in Medical Device Evaluation
The FDA has made significant strides in ensuring the safety and effectiveness of medical devices with the announcement of Ross Segan as the new Director of the Office of Product Evaluation and Quality (OPEQ).
Ross Segan's Experience and Vision
With a background in regulatory science, Segan's expertise is expected to push the FDA's medical device assessment processes forward, promoting innovation while prioritizing patient safety.
Importance of OPEQ's Role
- Evaluation of medical devices for public safety.
- Quality control measures for product evaluations.
- Encouraging collaboration between industry and regulators.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.